Join
Live feed
·
SECFilingvia Quantisnow
Amicus Therapeutics Inc. logo

Amicus Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
FOLD· Amicus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FOLD (Amicus Therapeutics Inc.) and more on Quantisnow.